Tags » Approval

Sign-off is for Sinners

Ah, the soothing sound of waterfalls, muffling the screams of those falling along with them.

It’s odd how often corporations choose to take the most long and painful approach to projects rather than just stopping them at the outset or, instead of actively constraining them of funds and resources, actually giving them everything they really need to succeed. 359 more words


What do I do if they don’t understand about law of attraction and everything I believe in?

When you are talking with someone who does not get you – and you want them to – the answer is not to continue the conversation. 28 more words

How To Allow

My socks don't match

My socks don’t match.  Today I wore two different gray ones.  Sometimes I just get crazy and wear a purple one and a brown one.   Unless I’m wearing shorts, I really don’t care.   128 more words

Lilly's lung cancer drug in combo with gemcitabine and cisplatin gets FDA's OK

Eli Lilly has gotten the U.S. Food and Drug Administration (FDA) approval for cancer drug Portrazza, which comes in a form of injection for intravenous use, 800 mg/50 mL, in combination with gemcitabine and cisplatin. 250 more words


Most People Can't Handle Being Profoundly Loved...

It’s true you know! Being profoundly loved isn’t as easy to accept as it might sound. I remember in one workshop I held where it was the first time I actively used the element of Profound Love deliberately in my work, my goodness the tears that arose as I called Profound Love into the space… 410 more words

Sharing From The Heart

Lupin gets a go-ahead to market Blisovi - generic version Warner Chilcott's Loestrin tablets - in U.S.

Pharma Major Lupin Limited (Lupin) has received final approvals for its Blisovi Fe 1/20 Tablets and Blisovi 1.5/30 Tablets from the United States Food and Drug Administration (FDA) to market generic versions of Warner Chilcott’s Loestrin Fe 1/20 Tablets and Loestrin Fe 1.5/30 Tablets. 91 more words


Futura Medical's two painkillers cleared path for Europe

Futura Medical, a transdermal technology specialist, has received by an European regulator clarity on the regulatory pathways for its two topical pain relief products, TPR100 (diclofenac) and TIB200 (ibuprofen). 271 more words